The effect of name-based reporting and partner notification on HIV testing in New York State

American Journal of Public Health

Volumn 98, Issue 4, 2008, Pages 728-735

  Tesoriero, James M ^a   Battles, Haven B ^a   Heavner, Karyn ^a   Leung, Shu Yin John ^a   Nemeth, Chris ^a   Pulver, Wendy ^a   Birkhead, Guthrie S ^b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AWARENESS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FUNDING; HEALTH BEHAVIOR; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; KNOWLEDGE; LAW; MALE; MEDICAID; MEDICAL DECISION MAKING; MEDICAL EXAMINATION; NOMENCLATURE; PATIENT COUNSELING; PREGNANCY; UNITED STATES; ADOLESCENT; ATTITUDE TO HEALTH; CONTACT EXAMINATION; DEMOGRAPHY; DIRECTIVE COUNSELING; INSTRUMENTATION; LEGAL ASPECT; MANDATORY REPORTING; MIDDLE AGED; RISK; SERODIAGNOSIS;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; CONTACT TRACING; DEMOGRAPHY; DIRECTIVE COUNSELING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MANDATORY REPORTING; MEDICAID; MIDDLE AGED; NEW YORK; ODDS RATIO; UNITED STATES;

EID: 85047681717     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2006.092742     Document Type: Article

References (33)

1. National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention. HIV/AIDS surveillance report: cases of HIV infection and AIDS in the United States and dependent areas. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/table14. htm. Accessed June 15, 2007.
2. Centers for Disease Control and Prevention. Twenty-five years of HIV/AIDS - United States, 1981-2006. MMWR Morb Mortal Wkly Rep. 2006;55(21):585-589.
3. Kegeles SM, Coates TJ, Lo B, Catania JA. Mandatory reporting of HIV testing would deter men from being tested. JAMA. 1989;261:1275-1276.
4. Fordyce EJ, Sambula S, Stoneburner R. Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being tested. JAMA. 1989;262:349.
5. Kegeles SM, Catania JA, Coates TJ, Pollack LM, Lo B. Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances. AIDS. 1990;4:585-587.
6. Myers T, Orr KW, Locker D, Jackson EA. Factors affecting gay and bisexual men's decisions and intentions to seek HIV testing. Am J Public Health. 1993;83:701-704.
7. HIV Testing Survey, 2002. Atlanta, Ga: Centers for Disease Control and Prevention; 2004.
8. Centers for Disease Control and Prevention. HIV testing among populations at risk for HIV infection - nine states, November 1995-December 1996. MMWR Morb Mortal Wkly Rep. 1998;47:1086-1091.
9. Hecht FM, Chesney MA, Lehman HS, et al. Does HIV reporting by name deter testing? AIDS. 2000;14:1801-1808.
10. Kellerman SE, Lehman JS, Lansky A, et al. HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr. 2002;31:202-210.
11. Lansky A, Lehman JS, Gatwood J, Hecht FM, Fleming PL. Changes in HIV testing after implementation of name-based HIV case surveillance in New Mexico. Am J Public Health. 2002;92:1757.
12. Osmond DH, Bindman AB, Vranizan K, et al. Name-based surveillance and public health interventions for persons with HIV infection. Ann Intern Med. 1999;131:775-779.
13. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. Can Med Assoc J. 2003;168:679-708.
14. Dolbear GL, Newell LT. Consent for prenatal testing: a preliminary examination of the effects of named HIV reporting and mandatory partner notification. J Public Health Manage Pract. 2002;8:69-77.
15. Nakashima AK, Horsley R, Frey RL, Sweeney PA, Weber JT, Fleming PL. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA. 1998;280:1421-1426.
16. Woods WJ, Binson D, Morin S, Dilley JW. HIV testing after implementation of name-based reporting [letter]. JAMA. 1999;281:1378.
17. Solomon L, Benjamin G, Wasserman M. HIV testing after implementation of name-based reporting [letter]. JAMA. 1999;281:1378-1379.
18. New York State Department of Health. Revised summary of regulatory impact statement. January 1999. Available at: http://www.health.state.ny.us/nysdoh/ rfa/hiv/sumrev.htm. Accessed June 15, 2007.
19. Centers for Disease Control and Prevention. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1999;48:1-32.
20. Fehrs LJ, Fleming D, Foster LR, et al. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet. 1998;2:379-382.
21. Berger SG, Hong BA, Eldridge S, Connor D, Vedder KN. Return rates and partner notification in HIV-positive men seeking anonymous versus confidential antibody testing. AIDS Patient Care STDS. 1999;13:363-368.
22. Hirano D, Gellert GA, Flemming K, Boyd D, Englender SJ. Hawks H. Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health. 1994;84:2008-2010.
23. Kassler W, Meriwether R, Klimko TB, Peterman TA, Zaidi A. Eliminating access to anonymous HIV antibody testing in North Carolina: effects on HIV testing and partner notification. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:281-289.
24. Hertz-Picciotto I, Lee LW, Hoyo C. HIV test-seeking before and after the restriction of anonymous testing in North Carolina. Am J Public Health. 1996;86:1446-1450.
25. New York State Department of Health AIDS Institute. The impact of New York's HIV Reporting and Partner Notification (HIVRPN) law: general findings report. 2005. Available at: http://www.nyhealth.gov/diseases/aids/regulations. Accessed June 15, 2007.
26. Torian LV, Bennari Y, Frieden TR. What is the true prevalence of HIV in New York City: estimating the number of undiagnosed and unreported persons living with HIV and AIDS, 2003. Poster presented at: the 12th Conference on Retroviruses and Opportunistic Infections; February 22-25, 2005; Boston, Mass.
27. Box GEP, Taio G. Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc. 1975;70:70.
28. Box GEP, Jenkins GM. Time Series Analysis: Forecasting and Control. San Francisco, Calif: Holden Day; 1975.
29. McDowall D, McCleary R, Meidinger E, Hay R. Interrupted Time Analysis. Beverly Hills, Calif: Sage Publications; 1988.
30. New York State Department of Health. Changes in the state's newborn HIV screening program - starting August 1, 1999. Available at: http://www.health. state.ny.us/disease/aids/newborn/index.htm. Accessed June 15, 2007.
31. Centers for Disease Control and Prevention. Number of persons tested for HIV - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53(47):1110-1113.
32. Centers for Disease Control and Prevention. HIV Testing - United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52:540-545.
33. Gerberding JL. Dear colleague letter regarding HIV surveillance. Centers for Disease Control and Prevention. 2005. Available at: http://www.cdc.gov/hiv/ topics/surveillance/index.htm. Accessed June 15, 2007.